EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 259 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $59,445 | -39.7% | 12,729 | -4.2% | 0.00% | -33.3% |
Q1 2024 | $98,612 | -13.2% | 13,290 | -8.7% | 0.00% | -25.0% |
Q3 2023 | $113,553 | -7.8% | 14,558 | -2.7% | 0.00% | 0.0% |
Q2 2023 | $123,179 | +16.6% | 14,967 | +2.7% | 0.00% | 0.0% |
Q1 2023 | $105,633 | -6.3% | 14,570 | +14.7% | 0.00% | 0.0% |
Q4 2022 | $112,685 | -44.5% | 12,704 | -23.5% | 0.00% | -50.0% |
Q3 2022 | $203,000 | +0.5% | 16,615 | -2.6% | 0.01% | +14.3% |
Q2 2022 | $202,000 | -28.6% | 17,059 | +14.7% | 0.01% | -12.5% |
Q1 2022 | $283,000 | -6.3% | 14,872 | +30.6% | 0.01% | 0.0% |
Q4 2021 | $302,000 | -33.2% | 11,388 | +3.5% | 0.01% | -42.9% |
Q3 2021 | $452,000 | +13.0% | 11,005 | +55.9% | 0.01% | +16.7% |
Q2 2021 | $400,000 | +41.3% | 7,061 | +74.9% | 0.01% | +20.0% |
Q4 2020 | $283,000 | +21.5% | 4,038 | -37.9% | 0.01% | -37.5% |
Q2 2018 | $233,000 | +7.4% | 6,507 | -0.7% | 0.02% | 0.0% |
Q1 2018 | $217,000 | – | 6,550 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deep Track Capital, LP | 6,000,000 | $28,020,000 | 0.84% |
Knott David M Jr | 177,000 | $827 | 0.33% |
Integral Health Asset Management, LLC | 675,000 | $3,152,250 | 0.30% |
Avidity Partners Management LP | 816,000 | $3,810,720 | 0.16% |
Green Alpha Advisors, LLC | 30,267 | $141,347 | 0.11% |
PDT Partners, LLC | 246,537 | $1,151,328 | 0.11% |
Spectrum Planning & Advisory Services Inc. | 12,051 | $57,122 | 0.06% |
Woodline Partners LP | 970,491 | $4,532,193 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 168,371 | $786,293 | 0.04% |
Virtus ETF Advisers LLC | 16,489 | $77,004 | 0.04% |